Post-Brexit, the UK’s Science and Technology sector is obliged to adopt a “wait and see” approach. The United Kingdom’s science and technology sector is braced for change following the country’s recent vote in favour of Brexit. Just as for big business, it was an unwelcome outcome for the scientific community, since UK based researchers collaborate with their peers across the EU in large numbers, not only at a cognitive level, but also in having access to world-leading shared research facilities.
In addition, there is concern that a brain drain out of the UK will now hit science, with those remaining in the UK anxious that their ongoing involvement in international collaborations is now at risk. On the regulatory front, there is already talk of the European Medicines Agency (EMA), at present based in London, moving to mainland Europe. The principal worry, unsurprisingly, relates to financial provision, with the EU currently responsible for a large slice of research funding through various grant programs and fellowships.